Induction Healthcare Group PLC - London-based software company serving healthcare providers and administrators - In the financial year to March 31, pretax loss narrows to £3.3 million from £17.4 million a year prior. Revenue climbs 5.6% to £14.4 million from £13.6 million. Posts adjusted earnings before interest, tax, depreciation and amortisation of £300,000, compared to loss of £4.0 million a year ago. Company says it achieved its objective of Ebitda breakeven having completed a cost containment and margin enhancement programme. Zesty revenue improves by 133% with strong pipeline for growth in financial 2025. Describes Zesty as its ‘growth engine’.

Current stock price: 12.68 pence

12-month change: down 40%

Copyright 2024 Alliance News Ltd. All Rights reserved.